Over the year to 31 March 2014 BACIT generated a return on net assets of 3.63% and a share price return of 9.62%. During this period the FTSE All-Share Index return was 8.81% and the return on the Hedge Fund Research Institute Fund of Funds Strategic Index was negative 2.53% (in sterling terms). They say the strength of Sterling relative to the dollar took 4.7% off the company’s return. The company made donations of £1,594,000 each to the Institute of Cancer Research and the BACIT Foundation. BACIT also invested £797,500 into one of the Institute of cancer Research’s early stage drug prospects (and will follow that up with more capital as the drug’s development progresses).
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated